compound, modified oligonucleotide, pharmaceutical composition, method for inhibiting the activity of one or more mir-17 family members in a cell and in a subject

• 收藏
• 分享

专利权人:

REGULUS THERAPEUTICS INC.

发明人:

CHARLES R. ALLERSON

申请号：

BR112019011164

公开号：

BR112019011164A2

申请日:

2017.12.04

申请国别(地区):

BR

年份:

2019

代理人:

摘要：

Methods for treating polycystic kidney disease, including autosomal dominant polycystic kidney disease, using mir-17-directed modified oligonucleotides are provided herein.são fornecidos neste documento métodos para o tratamento de doença renal policística, incluindo doença renal policística dominante autossômica, usando oligonucleotídeos modificados direcionados para mir-17.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/